Plasma B-Type Natriuretic Peptide Levels in Ambulatory Patients With Established Chronic Symptomatic Systolic Heart Failure
- 16 December 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 108 (24) , 2964-2966
- https://doi.org/10.1161/01.cir.0000106903.98196.b6
Abstract
Background— The diagnostic and prognostic values of plasma B-type natriuretic peptide (BNP) testing are established. However, the range of plasma BNP levels present in the setting of chronic, stable systolic heart failure (HF) is unclear. Methods and Results— We followed up 558 consecutive ambulatory patients with chronic, stable systolic HF (left ventricular ejection fraction Conclusions— In the ambulatory care setting, both symptomatic and asymptomatic patients with chronic, stable systolic HF may present with a wide range of plasma BNP levels. In a subset of symptomatic patients (up to 21% in our cohort), plasma BNP levels are below what would be considered “diagnostic” (<100 pg/mL).Keywords
This publication has 8 references indexed in Scilit:
- Heritability and Genetic Linkage of Plasma Natriuretic Peptide LevelsCirculation, 2003
- Impact of age and sex on plasma natriuretic peptide levels in healthy adultsThe American Journal of Cardiology, 2002
- Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart FailureNew England Journal of Medicine, 2002
- The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failureJournal of Cardiac Failure, 2002
- A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: A pilot studyJournal of Cardiac Failure, 2001
- A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot studyJournal of the American College of Cardiology, 2001
- Heart failure disease management: A team approachCleveland Clinic Journal of Medicine, 2001
- Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrationsThe Lancet, 2000